3 results
To determine the feasibility, toxicity and safety of anti-CEA x anti hapten bispecific antibodies (TF2) and Lu-177-labelled di-HSG-DOTA peptide (IMP-288) in patients with advanced colorectal carcinoma.
To assess the efficacy of blood pressure lowering and the safety of increasing doses of perindopril and amlodipine combination and to compare them to another validated antihypertensive strategy using valsartan and valsartan combined to amlodipine.
- Primary: Determine safety and feasibility of immuno-OCT in vivo imaging with the tracer Bevacizumab-800CW. - Secondary: Validate the immuno-OCT endoscopy system based on:o Fluorescence molecular endoscopy;o Ex vivo fluorescence imaging; o Ex vivo…